Produktinformation
- CyclosporinA, 11-L-leucine-
- 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.
- Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-L-leucyl]
Cyclosporine U is a cytostatic drug that is used to treat various types of cancers, including leukemia and lymphoma. It is also used to prevent rejection of transplanted organs. Cyclosporine U is available as a prescription drug and can be administered orally. The preparation of cyclosporine U involves the following steps: (1) the removal of l-norvaline from cyclosporine A; (2) the conversion of the resulting cyclosporine A to an ester with hplc analysis; and (3) the conversion of this ester to cyclosporine U by conjugation with phosphate derivatives. Cyclosporine U is not active against viruses or bacteria but has been shown to suppress the immune system by preventing T-cell activation and proliferation. Cyclosporine U binds specifically to T-lymphocytes, which are responsible for cell-mediated immunity, and prevents their activation. This binding inhibits production of interleuk
Chemische Eigenschaften
Technische Anfrage zu: 3D-FC35377 Cyclosporine U
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.